Iron out for nontransfused thalassemia. (otvara se novi prozor)

Marks PW.

Izvor‎: Blood 2012;120(5):928-9.

Indeks‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (otvara se novi prozor)

Iron overload in β-thalassemia intermedia: an emerging concern. (otvara se novi prozor)

Musallam KM, Cappellini MD, Taher AT.

Izvor‎: Curr Opin Hematol 2013;20(3):187-92.

Indeks‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (otvara se novi prozor)

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (otvara se novi prozor)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Izvor‎: Blood 2012;120(7):1531-2.

Indeks‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (otvara se novi prozor)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (otvara se novi prozor)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Izvor‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Indeks‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (otvara se novi prozor)

Therapeutic roles of curcumin: lessons learned from clinical trials. (otvara se novi prozor)

Gupta SC, Patchva S, Aggarwal BB.

Izvor‎: AAPS J 2013;15(1):195-218.

Indeks‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (otvara se novi prozor)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (otvara se novi prozor)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Izvor‎: J Med Assoc Thai 2012;95(1):29-36.

Indeks‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (otvara se novi prozor)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (otvara se novi prozor)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Izvor‎: Am J Hematol 2013;88(6):503-6.

Indeks‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (otvara se novi prozor)